Boatright Kelly M, Deis Cristina, Denault Jean-Bernard, Sutherlin Daniel P, Salvesen Guy S
Program in Apoptosis and Cell Death Research, The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Biochem J. 2004 Sep 1;382(Pt 2):651-7. doi: 10.1042/BJ20040809.
The first step in caspase activation is transition of the latent zymogen to an active form. For the initiator caspases, this occurs through dimerization of monomeric zymogens at an activating complex. Recent studies have suggested that FLIP(L) [FLICE-like inhibitory protein, long form; FLICE is FADD (Fas-associated death domain protein)-like interleukin-1beta-converting enzyme], previously thought to act solely as an inhibitor of caspase-8 activation, can under certain circumstances function to enhance caspase activation. Using an in vitro induced-proximity assay, we demonstrate that activation of caspases-8 and -10 occurs independently of cleavage of either the caspase or FLIP(L). FLIP(L) activates caspase-8 by forming heterodimeric enzyme molecules with substrate specificity and catalytic activity indistinguishable from those of caspase-8 homodimers. Significantly, the barrier for heterodimer formation is lower than that for homodimer formation, suggesting that FLIP(L) is a more potent activator of caspase-8 than is caspase-8 itself.
半胱天冬酶激活的第一步是潜在的酶原转变为活性形式。对于起始半胱天冬酶而言,这是通过单体酶原在激活复合物处二聚化而发生的。最近的研究表明,FLIP(L) [类FLICE抑制蛋白,长型;FLICE是FADD(Fas相关死亡结构域蛋白)样白介素-1β转化酶],以前被认为仅作为半胱天冬酶-8激活的抑制剂,在某些情况下可起到增强半胱天冬酶激活的作用。使用体外诱导接近分析,我们证明半胱天冬酶-8和-10的激活独立于半胱天冬酶或FLIP(L)的切割。FLIP(L)通过与具有与半胱天冬酶-8同型二聚体无法区分的底物特异性和催化活性的异源二聚体酶分子形成,来激活半胱天冬酶-8。重要的是,异源二聚体形成的障碍低于同型二聚体形成的障碍,这表明FLIP(L)是比半胱天冬酶-8本身更有效的半胱天冬酶-8激活剂。